Boston Scientific Corporation (NYSE:BSX) JUNE-26-2015 BUY av $18.09

COMPANY INFORMATION

Boston Scientific Corporation develops, manufactures and markets medical devices. The company offers its products for the seven businesses: interventional cardiology, including coronary stent drug-Systems designed intravascular imaging and coronary products, such as son guide, guide catheters and balloon catheters, including technology ; Peripheral Interventions (PI), including stents, balloon catheters, son, embolization of peripheral devices and vena cava filters; Cardiac Rhythm Management (CRM), which include implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities; Electrophysiology (EP), steerable catheters which RF, intracardiac ultrasound ablation catheters, diagnostic catheters, delivery sheaths, and other accessories; Endoscopy, including Spyglass system WallFlex® stents colon, video resolution, and wait needle aspiration, among others; Urology and women’s health and neuromodulation.